Free Trial

Cardiol Therapeutics (CRDL) Competitors

Cardiol Therapeutics logo
C$1.47 -0.08 (-5.16%)
As of 05/21/2025 04:00 PM Eastern

CRDL vs. DNA, TLRY, VBV, CUS, AIM, FRX, IPA, ITH, APM, and GXE

Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Dalradian Resources (DNA), Tilray Brands (TLRY), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), ImmunoPrecise Antibodies (IPA), International Tower Hill Mines (ITH), Andean Precious Metals (APM), and Gear Energy (GXE). These companies are all part of the "pharmaceutical products" industry.

Cardiol Therapeutics vs.

Dalradian Resources (TSE:DNA) and Cardiol Therapeutics (TSE:CRDL) are both small-cap basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, community ranking, institutional ownership, valuation, media sentiment and dividends.

Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Dalradian Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dalradian ResourcesN/AN/AN/A-C$0.03N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-2.89

In the previous week, Dalradian Resources' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Dalradian Resources Neutral
Cardiol Therapeutics Neutral

11.4% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dalradian Resources received 196 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. However, 69.23% of users gave Cardiol Therapeutics an outperform vote while only 66.78% of users gave Dalradian Resources an outperform vote.

CompanyUnderperformOutperform
Dalradian ResourcesOutperform Votes
205
66.78%
Underperform Votes
102
33.22%
Cardiol TherapeuticsOutperform Votes
9
69.23%
Underperform Votes
4
30.77%

Dalradian Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Dalradian ResourcesN/A N/A N/A
Cardiol Therapeutics N/A -195.07%-54.15%

Summary

Dalradian Resources and Cardiol Therapeutics tied by winning 4 of the 8 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRDL vs. The Competition

MetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$121.98MC$2.17BC$5.38BC$5.94B
Dividend YieldN/A2.92%5.21%6.32%
P/E Ratio-2.893.9726.8029.95
Price / SalesN/A552.76389.55752.53
Price / Cash0.9810.2538.2583.71
Price / Book9.847.186.803.96
Net Income-C$42.93MC$20.70BC$3.23BC$301.32M
7 Day Performance-7.55%-0.35%1.53%0.84%
1 Month Performance8.09%4.91%10.05%7.48%
1 Year Performance-50.67%89.90%16.75%16.03%

Cardiol Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
N/AC$1.47
-5.2%
N/A-51.6%C$121.98MN/A-2.8920News Coverage
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
TLRY
Tilray Brands
N/AC$0.63
-1.6%
N/A-76.8%C$405.95MC$610.34M-1.522,650
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060
AIM
Aimia
1.8118 of 5 stars
C$2.67
-0.7%
C$4.00
+49.8%
+1.8%C$256.79MC$464.71M-3.2820Gap Up
FRX
Fennec Pharmaceuticals
N/AC$8.66
-4.2%
N/A+17.9%C$167.01MC$34.86M-146.7010News Coverage
Insider Trade
Analyst Revision
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
ITH
International Tower Hill Mines
N/AC$1.04
-4.6%
N/A+9.3%C$146.01MN/A-43.45220
APM
Andean Precious Metals
2.1825 of 5 stars
C$1.29
+7.5%
C$2.00
+55.0%
+31.6%C$135.47MC$154.78M2.5530
GXE
Gear Energy
N/AN/AN/AN/AC$126.52MC$134.93M10.391,310

Related Companies and Tools


This page (TSE:CRDL) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners